IBDEI1XS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34377,1,4,0)
 ;;=4^J84.114
 ;;^UTILITY(U,$J,358.3,34377,2)
 ;;=^340536
 ;;^UTILITY(U,$J,358.3,34378,0)
 ;;=J84.09^^192^1998^2
 ;;^UTILITY(U,$J,358.3,34378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34378,1,3,0)
 ;;=3^Alveolar/Parieto-Alveolar Conditions NEC
 ;;^UTILITY(U,$J,358.3,34378,1,4,0)
 ;;=4^J84.09
 ;;^UTILITY(U,$J,358.3,34378,2)
 ;;=^5008299
 ;;^UTILITY(U,$J,358.3,34379,0)
 ;;=J67.2^^192^1998^3
 ;;^UTILITY(U,$J,358.3,34379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34379,1,3,0)
 ;;=3^Bird Fancier's Lung
 ;;^UTILITY(U,$J,358.3,34379,1,4,0)
 ;;=4^J67.2
 ;;^UTILITY(U,$J,358.3,34379,2)
 ;;=^14840
 ;;^UTILITY(U,$J,358.3,34380,0)
 ;;=J68.4^^192^1998^5
 ;;^UTILITY(U,$J,358.3,34380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34380,1,3,0)
 ;;=3^Chr Resp Cond d/t Chemicals/Gases/Fumes/Vapors
 ;;^UTILITY(U,$J,358.3,34380,1,4,0)
 ;;=4^J68.4
 ;;^UTILITY(U,$J,358.3,34380,2)
 ;;=^5008285
 ;;^UTILITY(U,$J,358.3,34381,0)
 ;;=M34.1^^192^1998^4
 ;;^UTILITY(U,$J,358.3,34381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34381,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,34381,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,34381,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,34382,0)
 ;;=J84.116^^192^1998^6
 ;;^UTILITY(U,$J,358.3,34382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34382,1,3,0)
 ;;=3^Cryptogenic Organizing Pneumonia
 ;;^UTILITY(U,$J,358.3,34382,1,4,0)
 ;;=4^J84.116
 ;;^UTILITY(U,$J,358.3,34382,2)
 ;;=^340539
 ;;^UTILITY(U,$J,358.3,34383,0)
 ;;=J84.117^^192^1998^7
 ;;^UTILITY(U,$J,358.3,34383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34383,1,3,0)
 ;;=3^Desquamative Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,34383,1,4,0)
 ;;=4^J84.117
 ;;^UTILITY(U,$J,358.3,34383,2)
 ;;=^340540
 ;;^UTILITY(U,$J,358.3,34384,0)
 ;;=M32.0^^192^1998^8
 ;;^UTILITY(U,$J,358.3,34384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34384,1,3,0)
 ;;=3^Drug-Induced Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,34384,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,34384,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,34385,0)
 ;;=M32.11^^192^1998^9
 ;;^UTILITY(U,$J,358.3,34385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34385,1,3,0)
 ;;=3^Endocarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,34385,1,4,0)
 ;;=4^M32.11
 ;;^UTILITY(U,$J,358.3,34385,2)
 ;;=^5011754
 ;;^UTILITY(U,$J,358.3,34386,0)
 ;;=J67.0^^192^1998^10
 ;;^UTILITY(U,$J,358.3,34386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34386,1,3,0)
 ;;=3^Farmer's Lung
 ;;^UTILITY(U,$J,358.3,34386,1,4,0)
 ;;=4^J67.0
 ;;^UTILITY(U,$J,358.3,34386,2)
 ;;=^44962
 ;;^UTILITY(U,$J,358.3,34387,0)
 ;;=M32.14^^192^1998^11
 ;;^UTILITY(U,$J,358.3,34387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34387,1,3,0)
 ;;=3^Glomerular Disease in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,34387,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,34387,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,34388,0)
 ;;=J67.9^^192^1998^12
 ;;^UTILITY(U,$J,358.3,34388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34388,1,3,0)
 ;;=3^Hypersensitivity Pneumonitis d/t Unspec Organic Dust
 ;;^UTILITY(U,$J,358.3,34388,1,4,0)
 ;;=4^J67.9
 ;;^UTILITY(U,$J,358.3,34388,2)
 ;;=^5008280
 ;;^UTILITY(U,$J,358.3,34389,0)
 ;;=J84.17^^192^1998^14
 ;;^UTILITY(U,$J,358.3,34389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34389,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,34389,1,4,0)
 ;;=4^J84.17
 ;;^UTILITY(U,$J,358.3,34389,2)
 ;;=^5008301
 ;;^UTILITY(U,$J,358.3,34390,0)
 ;;=J84.113^^192^1998^15
 ;;^UTILITY(U,$J,358.3,34390,1,0)
 ;;=^358.31IA^4^2
